Chinese Study: New Covid-19 Drug May Reduce Sperm Count
Chinese researchers has revealed that New COVID-19 drug, remdesivir which is under trial may reduce sperm count.
New COVID-19 drug, remdesivir, which is under clinical trial may reduce the sperm count in mice, a preliminary finding by Chinese researchers reveal.
The drug manufactured by Gilead Sciences Inc. was injected into 28 males and their sperm count and motility became low, according to the study conducted by Shenzhen Maternity and Child Healthcare Hospital and Shenzhen Second People’s Hospital showed.
According to the study, there were also an increased number of abnormalities in the sperm.
The study has not been peer reviewed, but was published on the biology pre-print website operated by Cold Spring Harbor Laboratory.
Meanwhile, China said it plans to announce the results from the clinical tests which was conducted in Wuhan on Monday.